PMA P020011S003
- Device
- VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY
- Applicant
- Gen-Probe
- PMA number
- P020011
- Supplement
- S003
- Product code
- MZP
- Decision date
- 2010-04-23
- Classification
- Assay, Hybridization And/or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,hepatitis C Virus
- Generic name
- Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
- Approval order statement
- CHANGE OF LOCATION FOR A QC LAB TO SEGREGATE THE PRE- AND POST-AMPLIFICATION STEPS INTO SEPARATE ROOMS.
Current openFDA PMA Record#
- Device
- VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY
- Applicant
- Gen-Probe
- PMA number
- P020011
- Supplement
- S003
- Product code
- MZP
- Generic name
- Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
- Decision date
- 2010-04-23
- Decision code
- OK30
- Date received
- 2010-03-31
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Approval order statement
- CHANGE OF LOCATION FOR A QC LAB TO SEGREGATE THE PRE- AND POST-AMPLIFICATION STEPS INTO SEPARATE ROOMS.